- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.25 Å
- Oligo State
- homo-trimer
- Ligands
- 12 x GOL: GLYCEROL(Non-functional Binders)
- 3 x J4X: 6-carbamimidoyl-N-phenyl-4-(pyrimidin-2-ylamino)naphthalene-2-carboxamide(Non-covalent)
J4X.5: 17 residues within 4Å:- Chain A: H.44, L.137, R.138, D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219
- Ligands: GOL.1
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:L.137, A:T.206
- Hydrogen bonds: A:D.182, A:D.182, A:A.183, A:S.188, A:G.211, A:G.211
- Water bridges: A:W.208, A:G.209, A:E.210
- pi-Cation interactions: A:K.185
J4X.14: 17 residues within 4Å:- Chain B: H.44, L.137, R.138, D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219
- Ligands: GOL.10
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:L.137, B:T.206
- Hydrogen bonds: B:D.182, B:D.182, B:A.183, B:S.188, B:G.211, B:G.211
- Water bridges: B:W.208, B:G.209, B:E.210
- pi-Cation interactions: B:K.185
J4X.23: 17 residues within 4Å:- Chain C: H.44, L.137, R.138, D.182, A.183, C.184, K.185, S.188, T.206, S.207, W.208, G.209, E.210, G.211, C.212, G.219
- Ligands: GOL.19
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:L.137, C:T.206
- Hydrogen bonds: C:D.182, C:D.182, C:A.183, C:S.188, C:G.211, C:G.211
- Water bridges: C:W.208, C:G.209, C:E.210
- pi-Cation interactions: C:K.185
- 12 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 4 residues within 4Å:- Chain A: K.195, W.200
- Ligands: GOL.3, GOL.4
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:K.195
SO4.7: 4 residues within 4Å:- Chain A: F.74, V.103, N.104, Q.109
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.104, A:N.104, A:Q.109
SO4.8: 8 residues within 4Å:- Chain A: K.117, R.120
- Chain B: K.117, R.120
- Chain C: K.117, R.120
- Ligands: SO4.17, SO4.26
9 PLIP interactions:2 interactions with chain A, 5 interactions with chain B, 2 interactions with chain C- Salt bridges: A:K.117, A:R.120, B:K.117, B:R.120, C:K.117, C:R.120
- Water bridges: B:R.120, B:R.120, B:R.120
SO4.9: 3 residues within 4Å:- Chain A: G.4, T.5, A.6
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:A.6
- Water bridges: A:Q.146, A:Q.146
SO4.15: 4 residues within 4Å:- Chain B: K.195, W.200
- Ligands: GOL.12, GOL.13
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:K.195
SO4.16: 4 residues within 4Å:- Chain B: F.74, V.103, N.104, Q.109
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.104, B:N.104, B:Q.109
SO4.17: 8 residues within 4Å:- Chain A: K.117, R.120
- Chain B: K.117, R.120
- Chain C: K.117, R.120
- Ligands: SO4.8, SO4.26
9 PLIP interactions:5 interactions with chain C, 2 interactions with chain A, 2 interactions with chain B- Water bridges: C:R.120, C:R.120, C:R.120
- Salt bridges: C:K.117, C:R.120, A:K.117, A:R.120, B:K.117, B:R.120
SO4.18: 3 residues within 4Å:- Chain B: G.4, T.5, A.6
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:A.6
- Water bridges: B:Q.146, B:Q.146
SO4.24: 4 residues within 4Å:- Chain C: K.195, W.200
- Ligands: GOL.21, GOL.22
2 PLIP interactions:2 interactions with chain C- Water bridges: C:E.11
- Salt bridges: C:K.195
SO4.25: 4 residues within 4Å:- Chain C: F.74, V.103, N.104, Q.109
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.104, C:N.104, C:Q.109
SO4.26: 8 residues within 4Å:- Chain A: K.117, R.120
- Chain B: K.117, R.120
- Chain C: K.117, R.120
- Ligands: SO4.8, SO4.17
9 PLIP interactions:2 interactions with chain C, 5 interactions with chain A, 2 interactions with chain B- Salt bridges: C:K.117, C:R.120, A:K.117, A:R.120, B:K.117, B:R.120
- Water bridges: A:R.120, A:R.120, A:R.120
SO4.27: 3 residues within 4Å:- Chain C: G.4, T.5, A.6
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:A.6
- Water bridges: C:Q.146, C:Q.146
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fjellstrom, O. et al., Creating Novel Activated Factor Xi Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design. Plos One (2015)
- Release Date
- 2015-02-11
- Peptides
- COAGULATION FACTOR XI: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.25 Å
- Oligo State
- homo-trimer
- Ligands
- 12 x GOL: GLYCEROL(Non-functional Binders)
- 3 x J4X: 6-carbamimidoyl-N-phenyl-4-(pyrimidin-2-ylamino)naphthalene-2-carboxamide(Non-covalent)
- 12 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Fjellstrom, O. et al., Creating Novel Activated Factor Xi Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design. Plos One (2015)
- Release Date
- 2015-02-11
- Peptides
- COAGULATION FACTOR XI: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A